Acquired
Novo Nordisk (Ozempic)
David Rosenthal
back to basically any interested pharma company. So like Eli Lilly back in the States, other companies in continental Europe. It's the new widely accepted, most advanced treatment for patients. Except there's one company that they refuse to license it to. And that is Novo.
0
💬
0
Comments
Log in to comment.
There are no comments yet.